USPTO serial 87150789
ONCOSIM
Reviewed by CopyMark Law Group
Reg. 5859680Status 710
- Filing date
- Status date
- Registration date
- Sep 17, 2019
- Examiner
- SWAIN, MICHELE LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ONCOSIM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Canadian Partnership Against Cancer
Toronto, Ontario, CA
Other trademarks owned by Canadian Partnership Against Cancer
Canadian Partnership Against Cancer
Toronto, Ontario, CA
Other trademarks owned by Canadian Partnership Against Cancer
Canadian Partnership Against Cancer
Toronto, Ontario, CA
Other trademarks owned by Canadian Partnership Against Cancer
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
Mary Margaret L. O'Donnell Blue Filament Law PLLC700 E. Maple RoadSuite 450Birmingham, MI 48009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electronic downloadable publications, namely, reports, bulletins, guides and statistical reports, in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support; downloadable video recordings featuring presentations, commentaries and interviews in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support | SECTION 8 - CANCELLED | — |
| 016 | Printed publications, namely, reports, bulletins, guides and statistical reports, in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support | SECTION 8 - CANCELLED | — |
| 036 | Providing a website featuring financial information concern cancer control and treatment funding | SECTION 8 - CANCELLED | — |
| 038 | Providing an on-line forum for exchanging information, experiences and ideas in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support | SECTION 8 - CANCELLED | — |
| 041 | On-line journals, namely, blogs featuring information in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support; education services, namely, seminars, educational non-downloadable webinars, workshops, presentations in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support and distribution of educational materials in connection therewith; providing a website featuring non-downloadable video recordings featuring presentations, commentaries and interviews in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support; providing a website featuring non-downloadable publications, namely, reports, bulletins, guides, whitepapers, newsletters, books, abstracts, journal articles, journals, magazine articles, and written editorials all in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support; providing online publications, namely, thematic summary documents in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support; providing education and training services, namely, organizing and offering seminars and conferences in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support | SECTION 8 - CANCELLED | — |
| 042 | Creating, maintaining and hosting a website to provide educational information and resources in the nature of online interactive tutorials, video recordings and information in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support; providing temporary use of non-downloadable computer software that collects and analyzes data relating to the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support; providing temporary use of non-downloadable computer software for use in the fields of population based modeling, simulation, and optimization for assessing and analyzing the impact of environmental, healthcare, health and economic variables related to cancer control and prevention on population health and the healthcare system; providing temporary use of non-downloadable computer software for analysis, modeling, and simulation of environmental, healthcare, health and economic variables related to cancer control and prevention | SECTION 8 - CANCELLED | — |
| 044 | Conducting medical policy research in the fields of cancer and related health system services; conducting medical policy research in the field of population based modeling, simulation, and optimization for assessing and analyzing the impact of environmental, healthcare, health and economic variables related to cancer control and prevention on population health and the healthcare system; conducting medical policy studies in the field of cancer-related health and lifestyle; medical policy research concerning trends, patterns and regional, national and international differences in relation to the causes and control of cancer; providing policy simulations and projections related to cancer control; providing a website featuring health information in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer guidelines, cancer treatment and therapeutic options, cancer patient and family support; providing medical and health consultation services in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support; Providing a website featuring health information in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer guidelines, cancer treatment and therapeutic options, cancer patient and family support; providing medical and health consultation services in the fields of disease of cancer, cancer prevention, cancer screening and detection, cancer diagnosis and clinical care, cancer research, cancer risk factors, cancer epidemiology, cancer health system resources, cancer health care policies, cancer control tools, cancer patient experience, cancer supportive care, cancer workforce, cancer guidelines, cancer control and treatment funding, cancer treatment and therapeutic options, cancer patient and family support | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Canadian Partnership Against Cancer
- Other trademarks owned by Canadian Partnership Against Cancer
- Other trademarks owned by Canadian Partnership Against Cancer
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 036
- Other trademarks in Class 038
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ONCOSIM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 27, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 29, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 29, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 29, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 29, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 29, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 29, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 17, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 17, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 15, 2019 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Aug 15, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 30, 2019 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jul 30, 2019 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Mar 19, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 22, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 22, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 2, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 16, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 11, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 10, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 10, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 3, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 3, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 3, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 3, 2018 | ZZAX | PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU | — |
| Aug 7, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 23, 2018 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jul 20, 2018 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 17, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 11, 2018 | DMCC | DATA MODIFICATION COMPLETED | — |
| Jul 11, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jun 23, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 22, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 22, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 3, 2018 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 3, 2018 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 3, 2018 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jun 8, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 8, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 8, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 5, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 5, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 6, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 31, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 29, 2016 | NWAP | NEW APPLICATION ENTERED | — |